Supplementary Figure S5 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
John Mascarenhas(Tisch Hospital), Ronald Hoffman(Icahn School of Medicine at Mount Sinai), Moshe Talpaz(University of Michigan), Rupali Bhave(Atrium Health Wake Forest Baptist), Maria Zingariello(Università Campus Bio-Medico), Kathryn Johnson(Icahn School of Medicine at Mount Sinai), Mario Falchi(Istituto Superiore di Sanità), Lilian Varricchio(Icahn School of Medicine at Mount Sinai), Noushin Farnoud(Memorial Sloan Kettering Cancer Center), Aaron T. Gerds(Cleveland Clinic), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Carolyn Mead‐Harvey(Mayo Clinic in Arizona), Heidi Kosiorek(Mayo Clinic in Florida), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Vesna Najfeld, Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Andrew Kuykendall(Moffitt Cancer Center), Rona Singer Weinberg(University of North Carolina at Chapel Hill), Jeanne Palmer(Mayo Clinic), Anna Ritá Migliaccio(Altius Institute for Biomedical Sciences), Kristen Pettit(University of Michigan), Marina Kremyanskaya(Tisch Cancer Institute), Frank Fabris(Icahn School of Medicine at Mount Sinai), Francesca Arciprete(Università Campus Bio-Medico), Abdulraheem Yacoub(The University of Kansas Cancer Center), Juan Arango Ossa(Memorial Sloan Kettering Cancer Center), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Dylan Domenico(Memorial Sloan Kettering Cancer Center), Agapito Gonzalez(The University of Texas at San Antonio Health Science Center), Amy Kong(Icahn School of Medicine at Mount Sinai), Erin McGovern, Mikaela Dougherty(Icahn School of Medicine at Mount Sinai), Amylou C. Dueck(Mayo Clinic in Arizona), Rami S. Komrokji(Moffitt Cancer Center)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k